Articles
All Items
-
Dyslipidemia and stroke-related mortality in the United States: a nationwide analysis for 2010-2020
435PDF: 145Supplementary: 41HTML: 35 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
540PDF: 189Supplementary: 57HTML: 21 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
341PDF: 350Supplementary: 172HTML: 44 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
937PDF: 269Supplementary: 190Appendix: 138HTML: 63 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
969PDF: 316Supplementary: 190Appendix: 139HTML: 94 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1554PDF: 768Appendix: 276HTML: 43 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2579PDF: 434Appendix B: 484Appendix A: 342HTML: 8 -
Pulmonary artery pressure sensor device performance in patients with atrial fibrillation/flutter
2807PDF: 473APPENDIX: 394HTML: 0 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2220PDF: 613SUPPLEMENTARY MATERIAL: 338GRAPHICAL ABSTRACT: 288HTML: 53 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1403pdf: 328Supplementary Material: 60HTML: 185

